Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis
暂无分享,去创建一个
K. Klingel | R. Kandolf | P. Fritz | U. Sechtem | A. Wagner | H. Mahrholdt | C. Bock | Eva-Maria Kispert | C. Deluigi | H. Vogelsberg | G. Meinhardt | J. Dippon | C. Bock | S. Hager | Stefan Hager
[1] J. Riquelme. Infección primaria por herpesvirus humano 6. A population-based study of primary human herpesvirus 6 infection. Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A, et al N Engl J Med 2005; 352 (5): 768-76 , 2005 .
[2] J. Lima,et al. Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. , 2005, Journal of the American College of Cardiology.
[3] H. Schultheiss,et al. Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction , 2005, Circulation.
[4] R. Kim,et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.
[5] U. Sigwart,et al. Current concepts of the pathogenesis and treatment of hypertrophic cardiomyopathy. , 2005, Circulation.
[6] D. Pennell,et al. Diagnosis of myocarditis by cardiovascular magnetic resonance , 2005, Heart.
[7] O. Pachinger,et al. Fatal course of parvovirus B19‐associated myocarditis in a female liver transplant recipient , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[8] A. Wald,et al. A population-based study of primary human herpesvirus 6 infection. , 2005, The New England journal of medicine.
[9] C. Prober. Sixth disease and the ubiquity of human herpesviruses. , 2005, The New England journal of medicine.
[10] R. Kandolf,et al. High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.
[11] C. Tschöpe,et al. High Prevalence of Cardiac Parvovirus B19 Infection in Patients With Isolated Left Ventricular Diastolic Dysfunction , 2005, Circulation.
[12] Wiley Interscience,et al. Quantitative analysis of human herpesvirus 6 cell tropism , 2005, Journal of medical virology.
[13] N. Rose,et al. Interferon- Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor- 1, Interleukin-1 , and Interleukin-4 in the Heart , 2004 .
[14] R. Kandolf. Virusätiologie der inflammatorischen Kardiomyopathie , 2004 .
[15] Udo Sechtem,et al. Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.
[16] Robert O. Bonow,et al. Heart Disease: A Textbook of Cardiovascular Medicine. 7th Edition , 2004 .
[17] N. Rose,et al. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. , 2004, The American journal of pathology.
[18] R. Kandolf. [Virus etiology of inflammatory cardiomyopathy]. , 2004, Deutsche medizinische Wochenschrift.
[19] K. Klingel,et al. Molecular pathology of inflammatory cardiomyopathy , 2004, Medical Microbiology and Immunology.
[20] K. Klingel,et al. Parvovirus B19 Infection Mimicking Acute Myocardial Infarction , 2003, Circulation.
[21] J. Towbin,et al. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. , 2003, Journal of the American College of Cardiology.
[22] C H Lorenz,et al. Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.
[23] M. Schoppet,et al. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. , 2003, Human pathology.
[24] H. Schultheiss,et al. Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction , 2003 .
[25] B. Maisch,et al. Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens. , 2003, Human pathology.
[26] K. Klingel,et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. , 2003, Human pathology.
[27] H. Schultheiss,et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. , 2003, Circulation.
[28] R. Kim,et al. Reproducibility of Chronic Infarct Size Measurement by Contrast-Enhanced Magnetic Resonance Imaging , 2002, Circulation.
[29] T. Yoshikawa,et al. Fatal acute myocarditis in an infant with human herpesvirus 6 infection. , 2001, Journal of clinical pathology.
[30] K. Klingel,et al. [Epstein-Barr virus-associated pericarditis]. , 2001, Deutsche medizinische Wochenschrift.
[31] O. Simonetti,et al. An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.
[32] S. Suvarna,et al. Necropsy diagnosis of myocarditis: a retrospective study using CD45RO immunohistochemistry , 2000, Journal of clinical pathology.
[33] O. Simonetti,et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. , 1999, Circulation.
[34] ChuichiKawai. From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death , 1999 .
[35] C. Kawai,et al. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. , 1999, Circulation.
[36] Heribert Schunkert,et al. Left-ventricular dysfunction , 1998, The Lancet.
[37] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[38] W. Roberts,et al. Gross and semiquantitative histologic findings in mononuclear cell myocarditis causing sudden death, and implications for endomyocardial biopsy. , 1993, The American journal of cardiology.
[39] K. Baughman,et al. A clinicopathologic description of myocarditis. , 1993, Clinical immunology and immunopathology.
[40] D. Krikler,et al. Heart disease: A textbook of cardiovascular medicine , 1992 .
[41] A. di Lenarda,et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. , 1992, American heart journal.
[42] G. Hutchins,et al. Clinicopathoiogic description of myocarditis , 1991 .
[43] E. Fisman,et al. Sudden unexpected death in persons <40 years of age , 1991 .
[44] E. Fisman,et al. Sudden unexpected death in persons less than 40 years of age. , 1991, The American journal of cardiology.
[45] W. Edwards,et al. Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.
[46] Lloyd M. Smith,et al. Fluorescence detection in automated DNA sequence analysis , 1986, Nature.
[47] J. Lefrère,et al. [Parvovirus B 19]. , 1986, Presse medicale.
[48] R. A. Johnson,et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. , 1985, The New England journal of medicine.
[49] M. Studdert,et al. Acute and chronic viral myocarditis. Acute diffuse nonsuppurative myocarditis and residual myocardial scarring following infection with canine parvovirus. , 1984, The American journal of pathology.
[50] C. Ray,et al. Acute polyarthritis associated with active Epstein-Barr virus infection. , 1982, JAMA.
[51] V. Fuster,et al. The natural history of idiopathic dilated cardiomyopathy. , 1981, The American journal of cardiology.
[52] E. Fletcher,et al. Cardiac complications of Coxsackie-virus infection. , 1957, Lancet.
[53] O. Saphir,et al. Myocarditis; a classification of 1402 cases. , 1947, American heart journal.